Developing countries may challenge intellectual property protection in biotechnology agreements.
The article discusses how protecting intellectual property in biotechnology is a big issue between rich and poor countries. The TRIPs agreement was made to settle this, but it might not work well. Trade measures may not make countries follow the rules, so negotiations might need to happen again.